C
Carlo M. Croce
Researcher at Ohio State University
Publications - 1156
Citations - 199822
Carlo M. Croce is an academic researcher from Ohio State University. The author has contributed to research in topics: microRNA & Cancer. The author has an hindex of 198, co-authored 1135 publications receiving 189007 citations. Previous affiliations of Carlo M. Croce include University of Nebraska Medical Center & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
Clinical significance of fragile histidine triad gene expression in adult acute lymphoblastic leukemia.
Maher Albitar,Taghi Manshouri,Cristi Gidel,Carlo M. Croce,Stephen Kornblau,Sherry Pierce,Hagop M. Kantarjian +6 more
TL;DR: It is confirmed that FHIT is aberrantly expressed in ALL, but suggests it does not have a role as a prognostic factor, and studies with large numbers of patients and evaluation of the mechanisms of FHit function in ALL are needed.
Patent
Methods for impairing the p53/hdm2 auto-regulatory loop in multiple myeloma development using mir-192, mir-194 and mir-215
Carlo M. Croce,Flavia Pichiorri +1 more
TL;DR: Methods and compositions for detecting, treating, characterizing, and diagnosing multiple myeloma are described in this article, where the authors also present a method to detect, treat, characterise, and diagnose the disease.
Journal Article
Significance of FHIT expression in chronic myelogenous leukemia
Hagop M. Kantarjian,Moshe Talpaz,Susan O'Brien,Taghi Manshouri,Jorge E. Cortes,Francis J. Giles,Mary Beth Rios,Carlo M. Croce,Maher Albitar +8 more
TL;DR: Reduced Fhit expression is not associated with progression, response to therapy, or prognosis in CML, and no differences in response to IFN-alpha therapy or in survival were observed by different Fhit levels.
Journal ArticleDOI
HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia
Sara Pagotto,Sara Pagotto,Angelo Veronese,Alessandra Soranno,Veronica Balatti,Alice Ramassone,Paolo Guanciali-Franchi,Giandomenico Palka,Idanna Innocenti,Francesco Autore,Laura Z. Rassenti,Thomas J. Kipps,Renato Mariani-Costantini,Luca Laurenti,Carlo M. Croce,Rosa Visone +15 more
TL;DR: The heterogeneous nuclear ribonucleoprotein L (HNRNPL) binds to the polymorphic marker D2S1888 at the 3′UTR of BUB1 gene, impairs the miR-155 targeting, and restores BUB 1 expression in chronic lymphocytic leukemia.
Journal ArticleDOI
Correction: Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation.
Zhaoyong Li,Mohammad Q. Hassan,Mohammed Jafferji,Rami I. Aqeilan,Ramiro Garzon,Carlo M. Croce,Andrew J. van Wijnen,Janet L. Stein,Gary S. Stein,Jane B. Lian +9 more
TL;DR: An Inquiry Committee at the University of Massachusetts Medical School determined that the error had no adverse effects on the conclusions reported in the publication, as multiple experimental approaches were presented that validated the findings.